Remarkably, in PD1+CD28− CD8+ T cells, ICOS was associated with highest polyfunctionality in periphery but was not beneficial at the tumor site (Fig. 4G), while it did not provide advantage to the CD28+ subgroup in any district (Fig. 4G and Fig. S5B). The gene discussed is CD28; the disease is neoplasm.